TickerFacts.

Company research / BTCY

BIOTRICITY INC. (BTCY)

Build a valuation ↗↓ Download CSV

CIK 0001630113 · OTC · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Mar 31

For the year ended 2026-03-31, BIOTRICITY INC. reported revenue of $16.00M. Revenue grew 16.0% from the prior annual period.

Key ratios (year ended 2026-03-31)

80.9%
Gross margin
10.6%
Operating margin
-15.0%
Net margin
16.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
Revenue$16.00M$13.79M$12.06M$9.64M$7.65M$3.38M$1.42M$398.2K——
Cost of Revenue$3.05M$3.23M$3.71M$4.20M$3.08M$2.11M$932.0K$338.3K——
Gross Profit$12.95M$10.56M$8.36M$5.44M$4.57M$1.27M$485.8K$59.9K——
Operating Income$1.69M-$2.45M-$8.83M-$15.41M-$16.74M—————
Net Income-$2.40M-$8.42M-$14.09M-$18.66M-$29.13M-$15.49M-$11.07M-$8.59M-$8.62M-$7.81M
EPS (Diluted)$-0.12$-0.56$-1.66$-2.26——————
Total Assets$6.45M$5.64M$5.94M$6.51M$16.68M$4.44M$2.00M$490.7K$929.4K$473.5K
Total Liabilities$39.41M$35.66M$35.92M$26.36M$18.82M$11.27M$5.00M$2.27M$756.2K$4.86M
Shareholders' Equity-$34.68M-$32.01M-$31.47M-$19.85M-$2.14M-$6.83M-$3.00M-$1.78M$173.2K-$4.38M
Cash & Equivalents$149.8K$365.1K$786.1K$570.5K$12.07M$2.20M$949.8K$63.6K$843.6K$424.9K
Operating Cash Flow-$719.0K-$2.38M-$6.69M-$13.55M-$15.16M-$11.08M-$7.86M-$5.22M-$4.87M-$3.75M
Capital Expenditures————$29.8K—————
Shares Outstanding28.60M26.08M9.35M8.51M49.81M36.12M32.59M31.05M23.71M18.08M
Weighted Average Diluted Shares27.30M21.52M8.99M8.66M——————
EPS (Basic)$-0.12$-0.56$-1.66$-2.26$-0.67$-0.44————